Publicacións en colaboración con investigadores/as de Hospital Xeral Calde (12)

2014

  1. Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy

    Tumori, Vol. 100, Núm. 2, pp. 225-231

2013

  1. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis

    Leukemia, Vol. 27, Núm. 11, pp. 2149-2156

2010

  1. Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

    European Journal of Haematology, Vol. 85, Núm. 4, pp. 321-328

  2. Relación entre presencia de comorbilidad y control del asma

    Archivos de Bronconeumologia, Vol. 46, Núm. 10, pp. 508-513

2008

  1. Coexistencia de Síndrome Lifoproliferativo Crónico y Síndrome Mieloproliferativo Crónico en tres pacientes

    Anales de Medicina Interna, Vol. 25, Núm. 2, pp. 78-80

2004

  1. Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience

    Annals of Oncology, Vol. 15, Núm. 10, pp. 1504-1509

2003

  1. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses

    Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758

  2. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

    Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151

2001

  1. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARα isoforms: A study of the PETHEMA group

    British Journal of Haematology, Vol. 114, Núm. 1, pp. 99-103

1998

  1. Agranulocitosis por antitiroideos: A proposito de cuatro casos

    Farmacia Hospitalaria, Vol. 22, Núm. 4, pp. 213-215

1996

  1. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects

    Annals of Hematology, Vol. 72, Núm. 5, pp. 321-326

1991

  1. Abnormal proteolytic degradation of von willebrand factor after desmopressin infusion in a new subtype of von willebrand disease (ID)

    American Journal of Hematology, Vol. 36, Núm. 3, pp. 163-170